Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study
Donna R. Rivera(National Cancer Institute), Jeremy L. Warner(Brown University), Deborah B. Doroshow(Icahn School of Medicine at Mount Sinai), Jessica E. Hawley(Columbia University Irving Medical Center), Ali Raza Khaki(Palo Alto Institute), Dimitrios Farmakiotis(Brown University), Shilpa Gupta(Cleveland Clinic), Matthew D. Galsky(Icahn School of Medicine at Mount Sinai), Christopher A. Lemmon(Cleveland Clinic), Leslie A. Fecher(University of Pennsylvania), Brian I. Rini(Vanderbilt University Medical Center), Petros Grivas(Seattle Cancer Care Alliance), Sanjay Goel(Rutgers, The State University of New Jersey), Ziad Bakouny(Dana-Farber Cancer Institute), Lidia Schapira(Palo Alto University), Michael A. Thompson(The University of Melbourne), Albert C. Yeh(University of Washington), Julie Wu(Palo Alto University), Chih–Yuan Hsu(Vanderbilt University Medical Center), Nicole M. Kuderer, Dimpy P. Shah(The University of Texas MD Anderson Cancer Center), Zhuoer Xie(Mayo Clinic), Corrie Painter, Toni K. Choueiri(Harvard University), Sanjay G. Revankar, Adam J. Olszewski(Memorial Hospital of Rhode Island), Sanjay Mishra(Vanderbilt University Medical Center), Yu Shyr(Vanderbilt University), Solange Peters(University Hospital of Lausanne), Christopher R. Friese(University of Michigan), Gilberto Lopes(University of Miami), Jonathan Arcobello(The Barbara Ann Karmanos Cancer Institute), Gary H. Lyman(University of Washington), Matthew Puc(Virtua Health), Samuel M. Rubinstein(Vanderbilt University Medical Center), Orestis A. Panagiotou(Brown University), Balázs Halmos(Montefiore Medical Center), Brendan J. Lee(Vanderbilt University Medical Center), Sumit Shah(Palo Alto University), Andrew Schmidt(Dana-Farber Cancer Institute), Þorvarður R. Hálfdánarson(Mayo Clinic), Pamela Egan(Brown University), Nathan A. Pennell(Cleveland Clinic), Huili Zhu(Yantai University), Gary K. Schwartz(Baylor University Medical Center)
Cited by 138
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.2k
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k